On to the road to degradation: atherosclerosis and the proteasome
Open Access
- 8 October 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 85 (2), 291-302
- https://doi.org/10.1093/cvr/cvp333
Abstract
Protein metabolism is a central element of every living cell. The ubiquitin-proteasome system (UPS) is an integral part of the protein metabolism machinery mediating post-transcriptional processing and degradation of the majority of intracellular proteins. Over the past few years, remarkable progress has been made in our understanding of the role of the UPS in vascular biology and pathobiology, particularly atherosclerosis. This review reflects on the recent developments from the effects on endothelial cells and the initial stage of atherosclerosis to the effects on vascular smooth muscle and the progression stage of atherosclerosis and finally to the effects on cell viability and the complication stage of atherosclerosis. It will conclude with the integration of the available information in a synoptic view of the involvement of the UPS in atherosclerosis.Keywords
This publication has 99 references indexed in Scilit:
- The functional variant rs1048990 in PSMA6 is associated with susceptibility to myocardial infarction in a Chinese populationAtherosclerosis, 2009
- Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient miceBasic Research in Cardiology, 2009
- Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer PathogenesisPPAR Research, 2008
- Chaperone-dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclaseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- SNPs of the PSMA6 gene: Investigation of possible association with myocardial infarction and type 2 diabetes mellitusRussian Journal of Genetics, 2007
- Morning Blood Pressure Surge as a Destabilizing Factor of Atherosclerotic PlaqueHypertension, 2007
- Proteasomal chymotrypsin‐like peptidase activity is required for essential functions of human monocyte‐derived dendritic cellsImmunology, 2007
- Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cellsFree Radical Biology & Medicine, 2006
- A proteasomal stress response: pre‐treatment with proteasome inhibitors increases proteasome activity and reduces neuronal vulnerability to oxidative injuryJournal of Neurochemistry, 2004
- On and off: proteasome and TGF-β signalingExperimental Cell Research, 2003